NeoGenomics Inc.

NASDAQ: NEO · Real-Time Price · USD
6.21
0.01 (0.16%)
At close: Aug 15, 2025, 3:59 PM
6.29
1.21%
After-hours: Aug 15, 2025, 06:17 PM EDT

NeoGenomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
660.57M 591.64M 509.73M 484.33M
Cost of Revenue
370.47M 347.04M 321.83M 297.27M
Gross Profit
290.1M 244.6M 187.9M 187.06M
Operating Income
-92.11M -107.74M -157.62M -118.75M
Interest Income
18.43M 16.9M 6.08M 3.14M
Pretax Income
-80.67M -97.1M -159.34M -15.07M
Net Income
-78.73M -87.97M -144.25M -8.35M
Selling & General & Admin
310.49M 279.96M 277.91M 283.94M
Research & Development
31.16M 27.31M 30.33M 21.87M
Other Expenses
40.55M 45.07M 37.29M n/a
Operating Expenses
382.21M 352.34M 345.52M 305.81M
Interest Expense
6.62M 6.91M 7.58M 8.22M
Selling & Marketing Expenses
84.63M 70.84M 67.32M 62.59M
Cost & Expenses
752.67M 699.38M 667.35M 603.08M
Income Tax Expense
-1.95M -9.13M -15.09M -6.73M
Shares Outstanding (Basic)
25.33M 25.1M 24.84M 23.99M
Shares Outstanding (Diluted)
25.33M 25.1M 24.84M 23.99M
EPS (Basic)
-3.1 -3.5 -5.8 -0.35
EPS (Diluted)
-3.1 -3.5 -5.8 -0.35
EBITDA
-1.51M -17.61M -82.33M -65.4M
EBIT
-74.06M -90.19M -151.76M -118.75M
Depreciation & Amortization
72.55M 72.58M 69.43M 53.35M